Viridian Therapeutics Shares Plummet: The Connection to an Amgen Study Explained.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 06 2026
0mins
Should l Buy SF?
Source: Barron's
- Viridian Therapeutics Stock Reaction: Viridian Therapeutics' stock experienced a decline on Monday.
- Amgen's Phase 3 Trial Results: The drop followed Amgen's announcement of positive results from a Phase 3 trial for a new treatment targeting thyroid eye disease.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SF?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SF
Wall Street analysts forecast SF stock price to rise
6 Analyst Rating
5 Buy
1 Hold
0 Sell
Strong Buy
Current: 80.760
Low
133.00
Averages
143.67
High
155.00
Current: 80.760
Low
133.00
Averages
143.67
High
155.00
About SF
Stifel Financial Corp. is a financial holding company. The Company's principal subsidiary is Stifel, Nicolaus & Company, Incorporated, a full-service retail and institutional wealth management and investment banking company. The Company’s segments include Global Wealth Management, Institutional Group, and Other. Its Global Wealth Management segment provides securities transaction, brokerage, and investment services to its clients through the consolidated Stifel branch system. The Institutional Group segment includes research, equity and fixed income institutional sales and trading, investment banking, public finance, and syndicate. The Other segment includes interest income from stock borrowing activities, unallocated interest expense, interest income and gains and losses from investments held, amortization of stock-based awards for certain administrative associates; and all unallocated overhead costs associated with the execution of orders; custody of client securities, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
ENCORE: UNDERWRITERS FOR IPO INCLUDE ROTHSCHILD & CO, STIFEL, WILLIAM BLAIR, WOLFE, NOMURA ALLIANCE, LIONTREE, THE RAINE GROUP, AND BLACKSTONE CAPITAL MARKETS
- Underwriters for IPO: Rothschild & Co, Stifel, William Blair, Wolfe, Nomura, Alliance, LionTree, The Raine Group, and Blackstone Capital Markets are the underwriters for the upcoming IPO.
- Company Focus: The IPO is likely to attract attention due to the involvement of prominent financial institutions and investment firms.
See More
Stifel Financial Corp. Appoints New Managing Director
- New Leadership Appointment: Erica Yoon joins Stifel as Managing Director in the Equity Sales group, focusing on the Technology, Media, and Telecommunications (TMT) sector, which is expected to enhance relationships with institutional investors and expand the firm's market reach.
- Extensive Industry Experience: With over 20 years in TMT sales, Yoon previously served as Managing Director at TD Cowen, successfully connecting clients with the firm's research, investment banking, and corporate access services, thereby enhancing service capabilities.
- Team Expansion: Yoon's addition will strengthen Stifel's TMT team, which includes sector sales specialists and 20 research analysts covering nearly 200 publicly traded TMT companies, further boosting the firm's competitive position in the market.
- Educational Background: Yoon holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from Wellesley College, reflecting her solid academic foundation and professional expertise in the industry.
See More
Stifel Financial Corp. Appoints New Managing Director
- New Leadership Appointment: Erica Yoon has joined Stifel Financial Corp. as a Managing Director, specializing in the Technology, Media, and Telecommunications (TMT) sector, bringing over 20 years of industry experience that is expected to significantly enhance the firm's relationships with institutional investors.
- Rich Industry Background: Prior to joining Stifel, Yoon served as Managing Director in TMT Specialist Sales at TD Cowen, successfully connecting clients with the firm's research, investment banking, and corporate access services, thereby enhancing the company's competitive edge in the market.
- Team Expansion: Yoon's addition will collaborate with existing TMT sales specialists and a team of 20 research analysts covering nearly 200 publicly traded TMT companies, strengthening Stifel's influence in the global technology investing ecosystem.
- Educational Credentials: Yoon holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from Wellesley College, showcasing her solid academic foundation and professional capabilities that will bring deeper industry insights to Stifel.
See More
Viridian Therapeutics Shares Plummet: The Connection to an Amgen Study Explained.
- Viridian Therapeutics Stock Reaction: Viridian Therapeutics' stock experienced a decline on Monday.
- Amgen's Phase 3 Trial Results: The drop followed Amgen's announcement of positive results from a Phase 3 trial for a new treatment targeting thyroid eye disease.
See More
Nicolet Bankshares Added to KBW Nasdaq Regional Bank Index
- Index Inclusion Honor: Nicolet Bankshares' addition to the KBW Nasdaq Regional Bank Index marks a significant milestone in its 25-year journey, reflecting its leadership in the community banking sector.
- Asset Growth: With over $15 billion in assets and 100 locations, Nicolet demonstrates strong market influence in the Upper Midwest, further solidifying its business foundation.
- Unique Financing Background: The fact that Nicolet has never completed a traditional IPO or raised capital in public markets highlights its unique growth path and market recognition, boosting investor confidence.
- Management's Remarks: CEO Mike Daniels expressed gratitude towards employees, directors, customers, and communities, emphasizing the positive impact of this recognition on the company's future development and signaling broader market opportunities.
See More
Analyst Claims Arm Enhances Earnings Potential; Also Featuring Chewy, Quanta, and Other Stocks.
Report Overview: Recent reports from investment and research firms provide insights into analysts' perspectives on various companies.
Disclaimer: The views expressed in these reports do not reflect the opinions or recommendations of Barron’s.
Investment Services: Some report issuers may have existing or potential investment-banking relationships with the companies analyzed.
Purpose of Reports: The reports serve as a sampling of analyst thinking rather than definitive investment advice.
See More
ENCORE: UNDERWRITERS FOR IPO INCLUDE ROTHSCHILD & CO, STIFEL, WILLIAM BLAIR, WOLFE, NOMURA ALLIANCE, LIONTREE, THE RAINE GROUP, AND BLACKSTONE CAPITAL MARKETS
- Underwriters for IPO: Rothschild & Co, Stifel, William Blair, Wolfe, Nomura, Alliance, LionTree, The Raine Group, and Blackstone Capital Markets are the underwriters for the upcoming IPO.
- Company Focus: The IPO is likely to attract attention due to the involvement of prominent financial institutions and investment firms.
See More
Stifel Financial Corp. Appoints New Managing Director
- New Leadership Appointment: Erica Yoon joins Stifel as Managing Director in the Equity Sales group, focusing on the Technology, Media, and Telecommunications (TMT) sector, which is expected to enhance relationships with institutional investors and expand the firm's market reach.
- Extensive Industry Experience: With over 20 years in TMT sales, Yoon previously served as Managing Director at TD Cowen, successfully connecting clients with the firm's research, investment banking, and corporate access services, thereby enhancing service capabilities.
- Team Expansion: Yoon's addition will strengthen Stifel's TMT team, which includes sector sales specialists and 20 research analysts covering nearly 200 publicly traded TMT companies, further boosting the firm's competitive position in the market.
- Educational Background: Yoon holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from Wellesley College, reflecting her solid academic foundation and professional expertise in the industry.
See More
Stifel Financial Corp. Appoints New Managing Director
- New Leadership Appointment: Erica Yoon has joined Stifel Financial Corp. as a Managing Director, specializing in the Technology, Media, and Telecommunications (TMT) sector, bringing over 20 years of industry experience that is expected to significantly enhance the firm's relationships with institutional investors.
- Rich Industry Background: Prior to joining Stifel, Yoon served as Managing Director in TMT Specialist Sales at TD Cowen, successfully connecting clients with the firm's research, investment banking, and corporate access services, thereby enhancing the company's competitive edge in the market.
- Team Expansion: Yoon's addition will collaborate with existing TMT sales specialists and a team of 20 research analysts covering nearly 200 publicly traded TMT companies, strengthening Stifel's influence in the global technology investing ecosystem.
- Educational Credentials: Yoon holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from Wellesley College, showcasing her solid academic foundation and professional capabilities that will bring deeper industry insights to Stifel.
See More
Viridian Therapeutics Shares Plummet: The Connection to an Amgen Study Explained.
- Viridian Therapeutics Stock Reaction: Viridian Therapeutics' stock experienced a decline on Monday.
- Amgen's Phase 3 Trial Results: The drop followed Amgen's announcement of positive results from a Phase 3 trial for a new treatment targeting thyroid eye disease.
See More
Nicolet Bankshares Added to KBW Nasdaq Regional Bank Index
- Index Inclusion Honor: Nicolet Bankshares' addition to the KBW Nasdaq Regional Bank Index marks a significant milestone in its 25-year journey, reflecting its leadership in the community banking sector.
- Asset Growth: With over $15 billion in assets and 100 locations, Nicolet demonstrates strong market influence in the Upper Midwest, further solidifying its business foundation.
- Unique Financing Background: The fact that Nicolet has never completed a traditional IPO or raised capital in public markets highlights its unique growth path and market recognition, boosting investor confidence.
- Management's Remarks: CEO Mike Daniels expressed gratitude towards employees, directors, customers, and communities, emphasizing the positive impact of this recognition on the company's future development and signaling broader market opportunities.
See More
Analyst Claims Arm Enhances Earnings Potential; Also Featuring Chewy, Quanta, and Other Stocks.
Report Overview: Recent reports from investment and research firms provide insights into analysts' perspectives on various companies.
Disclaimer: The views expressed in these reports do not reflect the opinions or recommendations of Barron’s.
Investment Services: Some report issuers may have existing or potential investment-banking relationships with the companies analyzed.
Purpose of Reports: The reports serve as a sampling of analyst thinking rather than definitive investment advice.
See More
